This transcript has been edited for clarity. Jay H. Shubrook, DO: Hi. I'm Jay Shubrook, a professor of primary care at Touro University California in the College of Osteopathic Medicine and a ...

Most of the insulinmedication that people use today is made from bacteria that have been genetically modified to produce insulin that is identical to the kind made in the human pancreas, according to ...

Stability in the thermal, chemical, and mechanical domains are critical for proper development and delivery of therapeutic proteins. Proteins are frequently exposed to stress throughout purification, ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

Scientists inch closer to an autologous diabetes cell therapy that dodges the challenge of immune rejection, creating insulin-producing cells from the lining of the gut. As of 2025, an estimated 9.5 ...

“Insulin injections remain a daily burden for many patients,” said Associate Professor Shingo Ito. “Our peptide-based platform offers a new route to deliver insulin orally and may be applicable to ...

So-called 'smart' insulin took a step nearer to becoming a reality with a new study from Denmark, the United Kingdom, and the Czech Republic. Researchers reported in Nature that animal tests with an ...

In a proof of concept that may reshape the treatment landscape for insulin-dependent diabetes, scientists have demonstrated that human stomach cells can be reprogrammed to secrete insulin—potentially ...

New research indicates that an acute exercise session may improve isolated muscle insulin resistance in carriers of a TBC1D4 nonsense mutation, a variant linked to hyperinsulinaemia and elevated type ...